{"id":21752,"date":"2016-12-15T11:16:00","date_gmt":"2016-12-15T11:16:00","guid":{"rendered":"https:\/\/phoenix.correctiv.org\/current\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/"},"modified":"2018-10-02T13:02:06","modified_gmt":"2018-10-02T13:02:06","slug":"doctors-eagerly-welcome-big-pharmas-money","status":"publish","type":"post","link":"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/","title":{"rendered":"Doctors eagerly welcome big pharma’s money"},"content":{"rendered":"\n

Direct link to the database<\/a><\/p>\n

It was unprecedented: In late June, 54 pharmaceutical companies presented the amount of money they doled out to doctors in Germany. A total of 575 million euros flowed from pharmaceutical companies into the hands of more than 71,000 doctors, experts and medical institutions. Barely a third of these physicians were willing to have their names published alongside these numbers. But a joint collaboration with CORRECTIV and Spiegel Online led to the publishing of the first database to include the names of 20,489 physicians and how much money they received from the pharmaceutical industry in the past year. Any internet user can search this database for doctors<\/a> by name, city and zip code.<\/p>\n

Who are the doctors positioned at the top of the list? First is Dr. Hans Christoph Diener from Essen, who in the past year received more than 200,000 euros for lectures, consultations, trainings and other various expenses. Then\u00a0came Dr. Juergen Rockstroh from Bonn\u00a0with 148,000 euros, followed by\u00a0Bochum-based Dr. Albrecht Nauck, an endocrinologist that specializes in diabetes\u00a0with 128,000 euros and\u00a0another endocrinologist, Dr. Thomas Forst from Mainz with 100,000 euros.<\/p>\n

Although these four doctors are situated at the top, it\u00a0does not necessarily mean they pocketed the most money in Germany. They are simply the top \u201eearners\u201c of the doctors\u00a0willing to have their names released.<\/p>\n

Jens Schreiber, an internist from Magdeburg, accepted money from a record 11 different pharmaceutical companies last year. The highest of his 11 \u201esubsidies?\u201c An astonishing 24,000 euros\u00a0from the pharmaceutical company Novartis.<\/p>\n

The \u201eTransparency<\/strong>\u201c\u00a0Project<\/strong><\/p>\n

\u201cThe release of this data will increase understanding and acceptance for the cooperation between pharmaceutical companies and doctors\u201c, says Birgit Fischer, in praise of the data before its publication to the public.<\/p>\n

Fischer is Head of Sales for the Research Association of the Pharmaceutical Industry (VFA), a big pharma lobby based in Berlin. \u201eAccess to these numbers can help the public understand how doctors and pharmaceutical companies work together in the healthcare system.\u201c<\/p>\n

\n
\n\"20160620\n<\/picture>
\n
\n

Director of VfA Brigit Fischer and FSA CEO Holger Diener (left): \u201eMore trust in the pharma industry\u201c<\/p>\n<\/div>\n

\n

Markus Grill<\/p>\n<\/div>\n<\/figcaption><\/div>\n<\/figure>\n

The transparency project, however, has a major flaw: The data is nearly indecipherable for patients. The project requires the 54\u00a0participating companies to simply host documents, with the names of the thousands of doctors, somewhere on their website. In many instances, the documents were unreadable PDFs or only included the first name of the doctor. In other cases the city was listed, but not the zip code. Nowhere was there a\u00a0searchable and usable presentation of the data combined. And according to Holger Diener, the CEO of FSA, Germany\u2019s self-regulatory body of the pharmaceutical \u201eno such database is planned.\u201c<\/p>\n

Some companies even expressly forbid the use of their data. Gruenenthal, a\u00a0German pharmaceutical company, wrote on their website that \u201ethe release of this data in no way provides permission for the use or editing of this data.\u201c UCB Pharma also posted a warning: \u201eThe release of our data is under no condition a permission for visitors to the website to continue working with this data.\u201c<\/p>\n

A databank with 20,000 names<\/strong><\/p>\n

Despite these warnings, CORRECTIV and Spiegel Online moved forward and used the\u00a0pharmaceutical companies\u2019 data to create a searchable,\u00a0and free to use, database. This is the first database in Germany that lists more than 20,000 doctors by\u00a0name and the exact sum of all finances given.<\/p>\n

A total of 119 million euros were paid to doctors for lectures, trainings and travel expenses in the last year. That amounts to an average of 1,646 euros for every doctor.<\/p>\n

Add to that another 366 million euros as payment for drug monitoring and other medical studies, which the companies refuse to provide additional information about. \u201eWe don\u2019t further differentiate in the research sector\u201c, says Birgit Fischer as she attempts to justify the current lack of transparency when it comes to drug monitoring and application observations. \u201eWhen made, this was a decision that we all agreed to.\u201c<\/p>\n

The pharmaceutical industry always argues that these observations are important for research, but Juergen Windeler, Head of the Institute for Quality and Economics in Health (IQWiG) finds this mildly funny. \u201eThese studies are scientifically worthless\u201c, he says. \u201eThey do not provide any worthwhile information about the use or effectiveness of a medication. That is why we don\u2019t even look at them.\u201c<\/p>\n

The payments influence doctors<\/strong><\/p>\n\n

For years experts have debated what influence, if any, pharmaceutical payments have on doctors. Most doctors believe they won\u2019t be influenced, even if they are sponsored by the industry. But then came an infamous study from a California hospital. Doctors working at the hospital were asked if their selection of medication was influenced by pharmaceutical referrals. 61 per cent said \u201enot at all.\u201c The study\u2019s designers then switched things around and asked whether the doctors felt their colleagues were influenced by pharmaceutical payments. This time 84 per cent of respondents said that they believe their colleagues are influenced.<\/p>\n

In Germany, Klaus Lieb is one of many who researches the impact of payments. He is director of the Clinic for Psychiatry and Psychotherapy at the University of Mainz. \u201eWe doctors have a blindspot when it comes to conflicts of interest. We let pharmaceutical companies pay for us and still believe we are independent.\u201c<\/p>\n

\n
\n\"LIEB_Klaus_\n<\/picture>
\n
\n

Klaus Lieb, Uniklinik Mainz: \u201eDoctors who attend pharma sponsored trainings prescribe on average more expensive drugs.\u201c<\/p>\n<\/div>\n

\n

Peter Pulkowski<\/p>\n<\/div>\n<\/figcaption><\/div>\n<\/figure>\n

Lieb published a study in the professional magazine Plos One that showed that doctors, who frequently meet with pharmaceutical reps, prescribe more medications than those who do not. “Moreover, doctors who attend pharma-sponsored training session prescribe higher priced drugs on average.\u201c Additionally, doctors closely affiliated with the pharmaceutical industry emphasize the benefits of medications and downplay the risks associated with the same drugs. \u201eIn the meantime, there is a very good database with all of these findings\u201c, Lieb say.<\/p>\n

An example from the US<\/strong><\/p>\n

Calculations from CORRECTIV and Spiegel Online show that only 29 per cent of doctors agreed to have their names released. This low number worries Lieb. \u201eTransparency looks different than this\u201c, he says. \u201e You can\u2019t start much with this on the individual level, especially compared to the Sunshine Act.\u201c<\/p>\n

The Physician Payments Sunshine Act is a law enacted by the US-government by President Barack Obama\u2019s leadership in 2010. It mandates that all pharmaceutical companies publish the amount of money and name of the doctor they provided compensation to, regardless of whether the doctor has agreed or not.<\/p>\n

\u201cNo laws planned\u201c<\/strong><\/p>\n

When asked whether there will be any changes to the transparency project, since such a low percentage of doctors agreed to have this data publish, Germany\u2019s Federal Health Minister, Hermann Groehe of the CDU party, says: \u201eThere are no additional regulations planned other than already existing transparency and corruption fighting regulations.\u201c Obama\u2019s Sunshine Act is not an option for Germany, he continued: \u201eThe rules in the US face criticism. Many argue that the presentation of payments to doctors and companies, without context, increases the likelihood they\u2019ll be seen as corrupt\u201c, the ministerium responded when questioned.<\/p>\n

Klaus Lieb from the University Clinic in Mainz views the release of money given to doctors as progress. \u201eWhen these payments are released, the doctors take their own conflicts of interest to heart. [The doctor] has to look them in the face and acquires a certain perspective. This helps him see past his blind spots.\u201c<\/p>\n

Peter Sawicki, who was a top drug checker for many years as head of the IQWIG<\/a>, sees the pharmaceutical industry\u2019s transparency guidelines purely as a campaign.<\/p>\n

\u201cThis is another measure to present themselves as clean to the public.\u201c He went on to stress that payments from the pharmaceutical industries massively influence doctors, a claim that is supported by multiple studies.\u201cIt is really time that we enact consequences, in light of these findings and a establish advanced training opportunities for doctors that are independent of big pharma-independent\u201c, he says. \u201eBut the political will is missing.\u201c<\/p>\n

\n

Contributors: Hristio Boytchev, Ariel Hauptmeier, Christoph Henrichs, Simon Jockers, Ivo Mayr, Philipp Seibt, Patrick Stotz, Achim Tack.<\/p>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"

Pharmaceutical companies have a history of being quite generous with physicians: They pay for their contracts, invite them to congressional meetings, pay for their hotel rooms, reward them for drug monitoring. A total of 575 million euros flowed from pharmaceutical companies into the hands of more than 71,000 doctors and medical experts this past year in Germany alone. But only 20,000 of these doctors are willing to have their name and the amount of money they\u2019ve accepted disclosed.<\/p>\n","protected":false},"author":1918,"featured_media":21750,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[93],"tags":[53],"class_list":["post-21752","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-euros-fuer-aerzte","tag-fuer-unsere-gesellschaft"],"acf":{"post::excerpt":"Pharmaceutical companies have a history of being quite generous with physicians: They pay for their contracts, invite them to congressional meetings, pay for their hotel rooms, reward them for drug monitoring. A total of 575 million euros flowed from pharmaceutical companies into the hands of more than 71,000 doctors and medical experts this past year in Germany alone. But only 20,000 of these doctors are willing to have their name and the amount of money they\u2019ve accepted disclosed.","post::authors":[1971,1918,1927],"post::related":[20584,21148,21641]},"cvui_categories":[{"id":93,"name":"Euros f\u00fcr \u00c4rzte","slug":"euros-fuer-aerzte"}],"cvui_featured_image":{"widget-post":{"url":"https:\/\/correctiv.org\/wp-content\/uploads\/2018\/10\/xray_blau-2-970x530.jpg","width":970,"height":530},"list":{"url":"https:\/\/correctiv.org\/wp-content\/uploads\/2018\/10\/xray_blau-2-706x386.jpg","width":706,"height":386},"thumbnail":{"url":"https:\/\/correctiv.org\/wp-content\/uploads\/2018\/10\/xray_blau-2-220x220.jpg","width":220,"height":220},"full":{"url":"https:\/\/correctiv.org\/wp-content\/uploads\/2018\/10\/xray_blau-2-scaled.jpg","width":3000,"height":1772}},"cvui_featured_image_alt":"","cvui_yoast_metadesc":null,"yoast_head":"\nDoctors eagerly welcome big pharma's money - correctiv.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Doctors eagerly welcome big pharma's money\" \/>\n<meta property=\"og:description\" content=\"Pharmaceutical companies have a history of being quite generous with physicians: They pay for their contracts, invite them to congressional meetings, pay for their hotel rooms, reward them for drug monitoring. A total of 575 million euros flowed from pharmaceutical companies into the hands of more than 71,000 doctors and medical experts this past year in Germany alone. But only 20,000 of these doctors are willing to have their name and the amount of money they\u2019ve accepted disclosed.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/\" \/>\n<meta property=\"og:site_name\" content=\"correctiv.org\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/correctiv.org\" \/>\n<meta property=\"article:published_time\" content=\"2016-12-15T11:16:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-10-02T13:02:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/correctiv.org\/wp-content\/uploads\/2018\/10\/xray_blau-2-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"3000\" \/>\n\t<meta property=\"og:image:height\" content=\"1772\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Markus Grill\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@correctiv_org\" \/>\n<meta name=\"twitter:site\" content=\"@correctiv_org\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Markus Grill\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/\"},\"author\":{\"name\":\"Markus Grill\",\"@id\":\"https:\/\/correctiv.org\/#\/schema\/person\/0fa4569d0052b7897e43e4d965541594\"},\"headline\":\"Doctors eagerly welcome big pharma’s money\",\"datePublished\":\"2016-12-15T11:16:00+00:00\",\"dateModified\":\"2018-10-02T13:02:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/\"},\"wordCount\":1348,\"publisher\":{\"@id\":\"https:\/\/correctiv.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/correctiv.org\/wp-content\/uploads\/2018\/10\/xray_blau-2-scaled.jpg\",\"keywords\":[\"F\u00fcr unsere Gesellschaft\"],\"articleSection\":[\"Euros f\u00fcr \u00c4rzte\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2016\",\"copyrightHolder\":{\"@id\":\"https:\/\/correctiv.org\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/\",\"url\":\"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/\",\"name\":\"Doctors eagerly welcome big pharma's money - correctiv.org\",\"isPartOf\":{\"@id\":\"https:\/\/correctiv.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/correctiv.org\/wp-content\/uploads\/2018\/10\/xray_blau-2-scaled.jpg\",\"datePublished\":\"2016-12-15T11:16:00+00:00\",\"dateModified\":\"2018-10-02T13:02:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/#primaryimage\",\"url\":\"https:\/\/correctiv.org\/wp-content\/uploads\/2018\/10\/xray_blau-2-scaled.jpg\",\"contentUrl\":\"https:\/\/correctiv.org\/wp-content\/uploads\/2018\/10\/xray_blau-2-scaled.jpg\",\"width\":3000,\"height\":1772},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/correctiv.org\/en\/correctiv-investigations-in-the-public-interest\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Doctors eagerly welcome big pharma’s money\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/correctiv.org\/#website\",\"url\":\"https:\/\/correctiv.org\/\",\"name\":\"correctiv.org\",\"description\":\"Recherchen f\u00fcr die Gesellschaft\",\"publisher\":{\"@id\":\"https:\/\/correctiv.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/correctiv.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/correctiv.org\/#organization\",\"name\":\"CORRECTIV\",\"url\":\"https:\/\/correctiv.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/correctiv.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/correctiv.org\/wp-content\/uploads\/2022\/01\/Logo-without-claim.svg\",\"contentUrl\":\"https:\/\/correctiv.org\/wp-content\/uploads\/2022\/01\/Logo-without-claim.svg\",\"width\":1,\"height\":1,\"caption\":\"CORRECTIV\"},\"image\":{\"@id\":\"https:\/\/correctiv.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/correctiv.org\",\"https:\/\/x.com\/correctiv_org\",\"https:\/\/www.instagram.com\/correctiv_org\",\"https:\/\/de.linkedin.com\/company\/correctiv\",\"https:\/\/www.youtube.com\/channel\/UCZ-tUoJJV-18Xtcij_tOgGQ\",\"https:\/\/de.wikipedia.org\/wiki\/Correctiv\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/correctiv.org\/#\/schema\/person\/0fa4569d0052b7897e43e4d965541594\",\"name\":\"Markus Grill\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/49c2e9ea31b2411fd4a5c0c7a0af6923e16e12eff7dfad0546b40bf776a8c519?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/49c2e9ea31b2411fd4a5c0c7a0af6923e16e12eff7dfad0546b40bf776a8c519?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/49c2e9ea31b2411fd4a5c0c7a0af6923e16e12eff7dfad0546b40bf776a8c519?s=96&d=mm&r=g\",\"caption\":\"Markus Grill\"},\"url\":\"https:\/\/correctiv.org\/en\/autor\/markus-grill\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Doctors eagerly welcome big pharma's money - correctiv.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/","og_locale":"en_US","og_type":"article","og_title":"Doctors eagerly welcome big pharma's money","og_description":"Pharmaceutical companies have a history of being quite generous with physicians: They pay for their contracts, invite them to congressional meetings, pay for their hotel rooms, reward them for drug monitoring. A total of 575 million euros flowed from pharmaceutical companies into the hands of more than 71,000 doctors and medical experts this past year in Germany alone. But only 20,000 of these doctors are willing to have their name and the amount of money they\u2019ve accepted disclosed.","og_url":"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/","og_site_name":"correctiv.org","article_publisher":"https:\/\/www.facebook.com\/correctiv.org","article_published_time":"2016-12-15T11:16:00+00:00","article_modified_time":"2018-10-02T13:02:06+00:00","og_image":[{"width":3000,"height":1772,"url":"https:\/\/correctiv.org\/wp-content\/uploads\/2018\/10\/xray_blau-2-scaled.jpg","type":"image\/jpeg"}],"author":"Markus Grill","twitter_card":"summary_large_image","twitter_creator":"@correctiv_org","twitter_site":"@correctiv_org","twitter_misc":{"Written by":"Markus Grill","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/#article","isPartOf":{"@id":"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/"},"author":{"name":"Markus Grill","@id":"https:\/\/correctiv.org\/#\/schema\/person\/0fa4569d0052b7897e43e4d965541594"},"headline":"Doctors eagerly welcome big pharma’s money","datePublished":"2016-12-15T11:16:00+00:00","dateModified":"2018-10-02T13:02:06+00:00","mainEntityOfPage":{"@id":"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/"},"wordCount":1348,"publisher":{"@id":"https:\/\/correctiv.org\/#organization"},"image":{"@id":"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/#primaryimage"},"thumbnailUrl":"https:\/\/correctiv.org\/wp-content\/uploads\/2018\/10\/xray_blau-2-scaled.jpg","keywords":["F\u00fcr unsere Gesellschaft"],"articleSection":["Euros f\u00fcr \u00c4rzte"],"inLanguage":"en-US","copyrightYear":"2016","copyrightHolder":{"@id":"https:\/\/correctiv.org\/#organization"}},{"@type":"WebPage","@id":"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/","url":"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/","name":"Doctors eagerly welcome big pharma's money - correctiv.org","isPartOf":{"@id":"https:\/\/correctiv.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/#primaryimage"},"image":{"@id":"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/#primaryimage"},"thumbnailUrl":"https:\/\/correctiv.org\/wp-content\/uploads\/2018\/10\/xray_blau-2-scaled.jpg","datePublished":"2016-12-15T11:16:00+00:00","dateModified":"2018-10-02T13:02:06+00:00","breadcrumb":{"@id":"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/#primaryimage","url":"https:\/\/correctiv.org\/wp-content\/uploads\/2018\/10\/xray_blau-2-scaled.jpg","contentUrl":"https:\/\/correctiv.org\/wp-content\/uploads\/2018\/10\/xray_blau-2-scaled.jpg","width":3000,"height":1772},{"@type":"BreadcrumbList","@id":"https:\/\/correctiv.org\/en\/aktuelles\/euros-fuer-aerzte\/2016\/12\/15\/doctors-eagerly-welcome-big-pharmas-money\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/correctiv.org\/en\/correctiv-investigations-in-the-public-interest\/"},{"@type":"ListItem","position":2,"name":"Doctors eagerly welcome big pharma’s money"}]},{"@type":"WebSite","@id":"https:\/\/correctiv.org\/#website","url":"https:\/\/correctiv.org\/","name":"correctiv.org","description":"Recherchen f\u00fcr die Gesellschaft","publisher":{"@id":"https:\/\/correctiv.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/correctiv.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/correctiv.org\/#organization","name":"CORRECTIV","url":"https:\/\/correctiv.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/correctiv.org\/#\/schema\/logo\/image\/","url":"https:\/\/correctiv.org\/wp-content\/uploads\/2022\/01\/Logo-without-claim.svg","contentUrl":"https:\/\/correctiv.org\/wp-content\/uploads\/2022\/01\/Logo-without-claim.svg","width":1,"height":1,"caption":"CORRECTIV"},"image":{"@id":"https:\/\/correctiv.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/correctiv.org","https:\/\/x.com\/correctiv_org","https:\/\/www.instagram.com\/correctiv_org","https:\/\/de.linkedin.com\/company\/correctiv","https:\/\/www.youtube.com\/channel\/UCZ-tUoJJV-18Xtcij_tOgGQ","https:\/\/de.wikipedia.org\/wiki\/Correctiv"]},{"@type":"Person","@id":"https:\/\/correctiv.org\/#\/schema\/person\/0fa4569d0052b7897e43e4d965541594","name":"Markus Grill","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/49c2e9ea31b2411fd4a5c0c7a0af6923e16e12eff7dfad0546b40bf776a8c519?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/49c2e9ea31b2411fd4a5c0c7a0af6923e16e12eff7dfad0546b40bf776a8c519?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/49c2e9ea31b2411fd4a5c0c7a0af6923e16e12eff7dfad0546b40bf776a8c519?s=96&d=mm&r=g","caption":"Markus Grill"},"url":"https:\/\/correctiv.org\/en\/autor\/markus-grill\/"}]}},"_links":{"self":[{"href":"https:\/\/correctiv.org\/en\/wp-json\/wp\/v2\/posts\/21752","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/correctiv.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/correctiv.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/correctiv.org\/en\/wp-json\/wp\/v2\/users\/1918"}],"replies":[{"embeddable":true,"href":"https:\/\/correctiv.org\/en\/wp-json\/wp\/v2\/comments?post=21752"}],"version-history":[{"count":0,"href":"https:\/\/correctiv.org\/en\/wp-json\/wp\/v2\/posts\/21752\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/correctiv.org\/en\/wp-json\/wp\/v2\/media\/21750"}],"wp:attachment":[{"href":"https:\/\/correctiv.org\/en\/wp-json\/wp\/v2\/media?parent=21752"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/correctiv.org\/en\/wp-json\/wp\/v2\/categories?post=21752"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/correctiv.org\/en\/wp-json\/wp\/v2\/tags?post=21752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}